Shi-Zhen-An-Shen Decoction, a Herbal Medicine That Reverses Cuprizone-Induced Demyelination and Behavioral Deficits in Mice Independent of the Neuregulin-1 Pathway
Shi-Zhen-An-Shen decoction (SZASD), a Chinese herbal medicine that is a liquor extracted from plants by boiling, has been reported to be effective in treating schizophrenia. However, the mechanism is unclear. Abnormal demyelination has been implicated in schizophrenia. The aim of this study was to i...
Saved in:
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Neural Plasticity |
Online Access: | http://dx.doi.org/10.1155/2021/8812362 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832563243699142656 |
---|---|
author | Chao Ma Yan Wu Xinyao Liu Yi He Yuan Jia Pei Chen Dongqing Yin Yanzhe Ning Guoqiang Xing Zuoli Sun Hongxiao Jia |
author_facet | Chao Ma Yan Wu Xinyao Liu Yi He Yuan Jia Pei Chen Dongqing Yin Yanzhe Ning Guoqiang Xing Zuoli Sun Hongxiao Jia |
author_sort | Chao Ma |
collection | DOAJ |
description | Shi-Zhen-An-Shen decoction (SZASD), a Chinese herbal medicine that is a liquor extracted from plants by boiling, has been reported to be effective in treating schizophrenia. However, the mechanism is unclear. Abnormal demyelination has been implicated in schizophrenia. The aim of this study was to investigate the effect of SZASD on myelin in demyelinated mice exhibiting schizophrenia-like behaviors. Sixty male C57BL/6 mice were randomly divided into six groups (n=10 per group): (1) control group, (2) cuprizone (CPZ, a copper chelator that induced demyelination, 0.2% w/w)+saline, (3) CPZ+low-dose SZASD (8.65 g·kg-1·d-1), (4) CPZ+medium-dose SZASD (17.29 g·kg-1·d-1), (5) CPZ+high-dose SZASD (25.94 g·kg-1·d-1), and (6) CPZ+quetiapine (QTP, an atypical antipsychotic that served as a positive treatment control, 10 mg·kg-1·d-1). Mice in groups 2-6 were treated with CPZ added to rodent chow for six weeks to induce demyelination. During the last two weeks, these mice were given an oral gavage of sterile saline, SZASD, or quetiapine. Behavioral tests and brain analyses were conducted after the last treatment. The brain expression of myelin basic protein (MBP) and neuregulin-1 (NRG-1) was assessed using immunohistochemistry and Western blots. CPZ induced significant schizophrenia-like behaviors in the mice, including reduced nest-building activity and sensory gating deficits. Hyperlocomotor activity was accompanied by significant reductions in MBP expression in the corpus callosum, hippocampus, and cerebral cortex. However, both QTP and SZASD significantly reversed the schizophrenia-like behaviors and demyelination in CPZ-fed mice. The QTP and medium-dose SZASD resulted in better therapeutic effects compared to the low and high SZASD doses. Reduced NRG-1 expression was observed in CPZ-fed mice compared with controls, but neither QTP nor SZASD showed significant influence on NRG-1 expression in the hippocampus. Together, SZASD showed a therapeutic effect on demyelinated mice, and the improvement of demyelination might not be through the NRG-1 pathway. |
format | Article |
id | doaj-art-c229b103322c44d58a7c0b4bd355d033 |
institution | Kabale University |
issn | 2090-5904 1687-5443 |
language | English |
publishDate | 2021-01-01 |
publisher | Wiley |
record_format | Article |
series | Neural Plasticity |
spelling | doaj-art-c229b103322c44d58a7c0b4bd355d0332025-02-03T01:20:37ZengWileyNeural Plasticity2090-59041687-54432021-01-01202110.1155/2021/88123628812362Shi-Zhen-An-Shen Decoction, a Herbal Medicine That Reverses Cuprizone-Induced Demyelination and Behavioral Deficits in Mice Independent of the Neuregulin-1 PathwayChao Ma0Yan Wu1Xinyao Liu2Yi He3Yuan Jia4Pei Chen5Dongqing Yin6Yanzhe Ning7Guoqiang Xing8Zuoli Sun9Hongxiao Jia10The National Clinical Research Center for Mental Disorders & Beijing Key Laboratory of Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing, ChinaThe National Clinical Research Center for Mental Disorders & Beijing Key Laboratory of Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing, ChinaThe National Clinical Research Center for Mental Disorders & Beijing Key Laboratory of Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing, ChinaThe National Clinical Research Center for Mental Disorders & Beijing Key Laboratory of Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing, ChinaThe National Clinical Research Center for Mental Disorders & Beijing Key Laboratory of Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing, ChinaThe National Clinical Research Center for Mental Disorders & Beijing Key Laboratory of Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing, ChinaThe National Clinical Research Center for Mental Disorders & Beijing Key Laboratory of Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing, ChinaThe National Clinical Research Center for Mental Disorders & Beijing Key Laboratory of Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing, ChinaThe Affiliated Hospital and the 2nd Clinical Medical College of North Sichuan Medical University, Nanchong Central Hospital, Nanchong 637000, ChinaThe National Clinical Research Center for Mental Disorders & Beijing Key Laboratory of Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing, ChinaThe National Clinical Research Center for Mental Disorders & Beijing Key Laboratory of Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing, ChinaShi-Zhen-An-Shen decoction (SZASD), a Chinese herbal medicine that is a liquor extracted from plants by boiling, has been reported to be effective in treating schizophrenia. However, the mechanism is unclear. Abnormal demyelination has been implicated in schizophrenia. The aim of this study was to investigate the effect of SZASD on myelin in demyelinated mice exhibiting schizophrenia-like behaviors. Sixty male C57BL/6 mice were randomly divided into six groups (n=10 per group): (1) control group, (2) cuprizone (CPZ, a copper chelator that induced demyelination, 0.2% w/w)+saline, (3) CPZ+low-dose SZASD (8.65 g·kg-1·d-1), (4) CPZ+medium-dose SZASD (17.29 g·kg-1·d-1), (5) CPZ+high-dose SZASD (25.94 g·kg-1·d-1), and (6) CPZ+quetiapine (QTP, an atypical antipsychotic that served as a positive treatment control, 10 mg·kg-1·d-1). Mice in groups 2-6 were treated with CPZ added to rodent chow for six weeks to induce demyelination. During the last two weeks, these mice were given an oral gavage of sterile saline, SZASD, or quetiapine. Behavioral tests and brain analyses were conducted after the last treatment. The brain expression of myelin basic protein (MBP) and neuregulin-1 (NRG-1) was assessed using immunohistochemistry and Western blots. CPZ induced significant schizophrenia-like behaviors in the mice, including reduced nest-building activity and sensory gating deficits. Hyperlocomotor activity was accompanied by significant reductions in MBP expression in the corpus callosum, hippocampus, and cerebral cortex. However, both QTP and SZASD significantly reversed the schizophrenia-like behaviors and demyelination in CPZ-fed mice. The QTP and medium-dose SZASD resulted in better therapeutic effects compared to the low and high SZASD doses. Reduced NRG-1 expression was observed in CPZ-fed mice compared with controls, but neither QTP nor SZASD showed significant influence on NRG-1 expression in the hippocampus. Together, SZASD showed a therapeutic effect on demyelinated mice, and the improvement of demyelination might not be through the NRG-1 pathway.http://dx.doi.org/10.1155/2021/8812362 |
spellingShingle | Chao Ma Yan Wu Xinyao Liu Yi He Yuan Jia Pei Chen Dongqing Yin Yanzhe Ning Guoqiang Xing Zuoli Sun Hongxiao Jia Shi-Zhen-An-Shen Decoction, a Herbal Medicine That Reverses Cuprizone-Induced Demyelination and Behavioral Deficits in Mice Independent of the Neuregulin-1 Pathway Neural Plasticity |
title | Shi-Zhen-An-Shen Decoction, a Herbal Medicine That Reverses Cuprizone-Induced Demyelination and Behavioral Deficits in Mice Independent of the Neuregulin-1 Pathway |
title_full | Shi-Zhen-An-Shen Decoction, a Herbal Medicine That Reverses Cuprizone-Induced Demyelination and Behavioral Deficits in Mice Independent of the Neuregulin-1 Pathway |
title_fullStr | Shi-Zhen-An-Shen Decoction, a Herbal Medicine That Reverses Cuprizone-Induced Demyelination and Behavioral Deficits in Mice Independent of the Neuregulin-1 Pathway |
title_full_unstemmed | Shi-Zhen-An-Shen Decoction, a Herbal Medicine That Reverses Cuprizone-Induced Demyelination and Behavioral Deficits in Mice Independent of the Neuregulin-1 Pathway |
title_short | Shi-Zhen-An-Shen Decoction, a Herbal Medicine That Reverses Cuprizone-Induced Demyelination and Behavioral Deficits in Mice Independent of the Neuregulin-1 Pathway |
title_sort | shi zhen an shen decoction a herbal medicine that reverses cuprizone induced demyelination and behavioral deficits in mice independent of the neuregulin 1 pathway |
url | http://dx.doi.org/10.1155/2021/8812362 |
work_keys_str_mv | AT chaoma shizhenanshendecoctionaherbalmedicinethatreversescuprizoneinduceddemyelinationandbehavioraldeficitsinmiceindependentoftheneuregulin1pathway AT yanwu shizhenanshendecoctionaherbalmedicinethatreversescuprizoneinduceddemyelinationandbehavioraldeficitsinmiceindependentoftheneuregulin1pathway AT xinyaoliu shizhenanshendecoctionaherbalmedicinethatreversescuprizoneinduceddemyelinationandbehavioraldeficitsinmiceindependentoftheneuregulin1pathway AT yihe shizhenanshendecoctionaherbalmedicinethatreversescuprizoneinduceddemyelinationandbehavioraldeficitsinmiceindependentoftheneuregulin1pathway AT yuanjia shizhenanshendecoctionaherbalmedicinethatreversescuprizoneinduceddemyelinationandbehavioraldeficitsinmiceindependentoftheneuregulin1pathway AT peichen shizhenanshendecoctionaherbalmedicinethatreversescuprizoneinduceddemyelinationandbehavioraldeficitsinmiceindependentoftheneuregulin1pathway AT dongqingyin shizhenanshendecoctionaherbalmedicinethatreversescuprizoneinduceddemyelinationandbehavioraldeficitsinmiceindependentoftheneuregulin1pathway AT yanzhening shizhenanshendecoctionaherbalmedicinethatreversescuprizoneinduceddemyelinationandbehavioraldeficitsinmiceindependentoftheneuregulin1pathway AT guoqiangxing shizhenanshendecoctionaherbalmedicinethatreversescuprizoneinduceddemyelinationandbehavioraldeficitsinmiceindependentoftheneuregulin1pathway AT zuolisun shizhenanshendecoctionaherbalmedicinethatreversescuprizoneinduceddemyelinationandbehavioraldeficitsinmiceindependentoftheneuregulin1pathway AT hongxiaojia shizhenanshendecoctionaherbalmedicinethatreversescuprizoneinduceddemyelinationandbehavioraldeficitsinmiceindependentoftheneuregulin1pathway |